Shares of clinical stage biotech company Recursion Pharmaceuticals Inc RXRX are trading higher Tuesday. The company’s CEO Chris Gibson joined CNBC for an interview ahead of a presentation with Nvidia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback